Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Tags Academic Researcher To Probe Advisory Panel Conflicts Of Interest

This article was originally published in The Gray Sheet

Executive Summary

A joint conflict-of-interest study by FDA and the University of Maryland will survey attendees at the agency's April Circulatory System Devices Advisory Panel and National Mammography Quality Assurance Advisory Committee meetings, according to the project's primary investigator

You may also be interested in...



Silicone Implant Data Draw Further Criticism From Panel Chair, Public Citizen

Inamed failed to supply proof of long-term safety of its silicone breast implants to FDA and the General & Plastic Surgery Devices Panel, Public Citizen contends in a Nov. 3 petition

Silicone Implant Data Draw Further Criticism From Panel Chair, Public Citizen

Inamed failed to supply proof of long-term safety of its silicone breast implants to FDA and the General & Plastic Surgery Devices Panel, Public Citizen contends in a Nov. 3 petition

Blood Industry Reps Will Be Tapped Under “Realist” HHS Panel Approach

HHS will restructure its Blood Safety & Availability Advisory Committee to openly acknowledge industry reps as panel members, rather than retain company employees with the use of regulatory waivers

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT018083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel